Vivos Therapeutics (NASDAQ:VVOS) will participate in a fireside chat with Water Tower Research on February 18 at 12pm Eastern Time.
CEO Kirk Huntsman will discuss the company's Vivos CARE devices for obstructive sleep apnea (OSA), its strategic shift to a medical-based business model, efforts to form alliances with sleep physician groups, and the role of its devices in the OSA treatment landscape.